2seventy bio, Inc.
TSVT
$3.10
$0.4516.98%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 145.88M | 147.25M | 124.69M | 91.50M | 51.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 145.88M | 147.25M | 124.69M | 91.50M | 51.35M |
| Cost of Revenue | 257.95M | 263.79M | 272.39M | 274.95M | 270.27M |
| Gross Profit | -112.07M | -116.54M | -147.70M | -183.46M | -218.91M |
| SG&A Expenses | 71.91M | 78.52M | 76.31M | 79.45M | 85.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 329.86M | 342.31M | 348.70M | 354.40M | 355.50M |
| Operating Income | -183.98M | -195.06M | -224.01M | -262.91M | -304.14M |
| Income Before Tax | -183.91M | -180.15M | -215.48M | -254.17M | -291.99M |
| Income Tax Expenses | -17.00K | -17.00K | -17.00K | -17.00K | -- |
| Earnings from Continuing Operations | -183.89 | -180.13 | -215.46 | -254.15 | -291.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -183.89M | -180.13M | -215.46M | -254.15M | -291.99M |
| EBIT | -183.98M | -195.06M | -224.01M | -262.91M | -304.14M |
| EBITDA | -174.40M | -185.86M | -213.75M | -251.38M | -291.40M |
| EPS Basic | -3.91 | -4.27 | -5.46 | -7.58 | -9.53 |
| Normalized Basic EPS | -2.19 | -2.66 | -3.41 | -4.73 | -5.96 |
| EPS Diluted | -3.91 | -4.27 | -5.46 | -7.58 | -9.53 |
| Normalized Diluted EPS | -2.19 | -2.66 | -3.41 | -4.73 | -5.96 |
| Average Basic Shares Outstanding | 184.29M | 171.69M | 159.10M | 142.38M | 127.59M |
| Average Diluted Shares Outstanding | 184.29M | 171.69M | 159.10M | 142.38M | 127.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
